Fervent Synergies Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 31, 2025, 7:47 pm

Market Cap	89.1 Cr.
Current Price	20.4
High / Low	32.0/14.6
Stock P/E	30.2
Book Value	11.1
Dividend Yield	0.00 %
ROCE	7.47 %
ROE	7.47 %
Face Value	10.0
PEG Ratio	-1.10

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Fervent Synergies Ltd

Competitors of Fervent Synergies Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Lactose (India) Ltd	134 Cr.	95.0	247/84.3	26.0	41.7	0.00 %	12.9 %	9.75 %	10.0
MPS Pharmaa Ltd	5.27 Cr.	2.76	4.33/2.50		0.57	0.00 %	9.79 %	59.0 %	10.0
Gujarat Themis Biosyn Ltd	2,663 Cr.	244	390/192	50.6	20.5	0.27 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	39.9 Cr.	53.8	94.9/44.5		8.73	0.00 %	41.5 %	14.4 %	10.0
Gujarat Inject (Kerala) Ltd	41.1 Cr.	28.0	29.1/13.1	40.3	6.83	0.00 %	13.5 %	11.0 %	10.0
Industry Average	18,354.98 Cr	1,129.60		88.53	194.54	0.32%	16.70%	15.22%	6.19

All Competitor Stocks of Fervent Synergies Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	0.00	0.24	0.23	3.27	0.89	0.32	0.32	8.83	14.85	0.34	0.39	26.33	5.40
Expenses	0.21	0.18	0.16	3.08	0.74	0.18	0.18	8.32	28.40	0.26	0.34	23.97	4.90
Operating Profit	-0.21	0.06	0.07	0.19	0.15	0.14	0.14	0.51	-13.55	0.08	0.05	2.36	0.50
OPM %		25.00%	30.43%	5.81%	16.85%	43.75%	43.75%	5.78%	-91.25%	23.53%	12.82%	8.96%	9.26%
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.00	0.00	0.00	0.00
Depreciation	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Profit before tax	-0.22	0.05	0.06	0.18	0.14	0.13	0.13	0.50	-13.60	0.07	0.04	2.35	0.49
Tax %	13.64%	20.00%	33.33%	27.78%	100.00%	23.08%	23.08%	26.00%	-1.40%	0.00%	0.00%	0.00%	0.00%
Net Profit	-0.25	0.05	0.05	0.14	0.00	0.10	0.09	0.37	-13.41	0.07	0.04	2.35	0.50
EPS in Rs	-0.08	0.02	0.02	0.05	0.00	0.03	0.03	0.12	-4.47	0.02	0.01	0.54	0.11

Last Updated: May 31, 2025, 6:04 am

Below is a detailed analysis of the quarterly data for Fervent Synergies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 5.40 Cr.. The value appears to be declining and may need further review. It has decreased from 26.33 Cr. (Dec 2024) to 5.40 Cr., marking a decrease of 20.93 Cr..
For Expenses, as of Mar 2025, the value is 4.90 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 23.97 Cr. (Dec 2024) to 4.90 Cr., marking a decrease of 19.07 Cr..
For Operating Profit, as of Mar 2025, the value is 0.50 Cr.. The value appears to be declining and may need further review. It has decreased from 2.36 Cr. (Dec 2024) to 0.50 Cr., marking a decrease of 1.86 Cr..
For OPM %, as of Mar 2025, the value is 9.26%. The value appears strong and on an upward trend. It has increased from 8.96% (Dec 2024) to 9.26%, marking an increase of 0.30%.
For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
For Depreciation, as of Mar 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.01 Cr..
For Profit before tax, as of Mar 2025, the value is 0.49 Cr.. The value appears to be declining and may need further review. It has decreased from 2.35 Cr. (Dec 2024) to 0.49 Cr., marking a decrease of 1.86 Cr..
For Tax %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00%.
For Net Profit, as of Mar 2025, the value is 0.50 Cr.. The value appears to be declining and may need further review. It has decreased from 2.35 Cr. (Dec 2024) to 0.50 Cr., marking a decrease of 1.85 Cr..
For EPS in Rs, as of Mar 2025, the value is 0.11. The value appears to be declining and may need further review. It has decreased from 0.54 (Dec 2024) to 0.11, marking a decrease of 0.43.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 3:33 am

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	2	3	4	4	39	6	17	7	2	1	5	24	42
Expenses	0	0	1	1	36	4	15	7	2	1	4	37	53
Operating Profit	2	2	3	3	3	1	1	0	0	-0	0	-13	-11
OPM %	81%	81%	85%	82%	7%	20%	8%	6%	13%	-26%	10%	-53%	-26%
Other Income	-1	-0	0	-0	1	0	0	0	0	0	0	0	0
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0
Profit before tax	1	2	3	3	3	1	2	0	0	-0	0	-13	-11
Tax %	32%	33%	33%	34%	27%	27%	29%	26%	26%	20%	48%	0%
Net Profit	1	1	2	2	2	1	1	0	0	-0	0	-13	-11
EPS in Rs	0.23	0.53	0.65	0.64	0.80	0.28	0.41	0.08	0.06	-0.08	0.08	-4.28	-3.90
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020
YoY Net Profit Growth (%)	0.00%	100.00%	0.00%	0.00%	-50.00%	0.00%	-100.00%
Change in YoY Net Profit Growth (%)	0.00%	100.00%	-100.00%	0.00%	-50.00%	50.00%	-100.00%

Fervent Synergies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2013-2014 to 2019-2020.

Growth

Compounded Sales Growth
10 Years:	25%
5 Years:	35%
3 Years:	263%
TTM:	34%

Compounded Profit Growth
10 Years:	4%
5 Years:	65%
3 Years:	143%
TTM:	123%

Stock Price CAGR
10 Years:	-12%
5 Years:	13%
3 Years:	16%
1 Year:	22%

Return on Equity
10 Years:	-1%
5 Years:	-5%
3 Years:	-8%
Last Year:	7%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 1:43 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	25	25	30	30	30	30	30	30	30	30	30	30	30
Reserves	2	3	6	8	11	12	13	13	13	13	13	0	5
Borrowings	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0	1	1	1	1	0	1	1	1	0	0	0	0
Total Liabilities	27	29	37	39	42	42	43	43	44	43	43	31	36
Fixed Assets	0	0	0	0	2	4	18	18	18	16	16	8	8
CWIP	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	1	1	0	2	0	1	1	0	1	0	0	0	0
Other Assets	26	28	37	37	40	38	25	25	25	27	27	23	28
Total Assets	27	29	37	39	42	42	43	43	44	43	43	31	36

Below is a detailed analysis of the balance sheet data for Fervent Synergies Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 30.00 Cr..
For Reserves, as of Sep 2024, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 5.00 Cr., marking an increase of 5.00 Cr..
For Borrowings, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Liabilities, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Total Liabilities, as of Sep 2024, the value is 36.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.00 Cr. (Mar 2024) to 36.00 Cr., marking an increase of 5.00 Cr..
For Fixed Assets, as of Sep 2024, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
For CWIP, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Investments, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 23.00 Cr. (Mar 2024) to 28.00 Cr., marking an increase of 5.00 Cr..
For Total Assets, as of Sep 2024, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2024) to 36.00 Cr., marking an increase of 5.00 Cr..

Notably, the Reserves (5.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	-3.66	1.06	-6.28	-1.82	2.85	11.58	1.95	0.18	-2.19	-0.07	-0.20	-15.08
Cash from Investing Activity +	0.00	1.00	-2.14	1.19	-2.39	-14.03	-0.22	0.00	2.40	0.00	0.00	0.00
Cash from Financing Activity +	0.00	6.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.12
Net Cash Flow	-3.66	8.06	-8.41	-0.63	0.46	-2.46	1.73	0.18	0.21	-0.07	-0.20	0.04

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	2.00	2.00	3.00	3.00	3.00	1.00	1.00	0.00	0.00	0.00	0.00	-13.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	0	0	0	0	43	46	66	132	289	0	47	0
Inventory Days					12	0	0	81	0		0	0
Days Payable					0			0
Cash Conversion Cycle	0	0	0	0	55	46	66	212	289	0	47	0
Working Capital Days	1,395	1,993	1,590	2,337	256	1,437	249	482	3,260	14,332	2,132	345
ROCE %	7%	7%	9%	8%	8%	3%	4%	1%	1%	-0%	1%	-35%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	70.56%	70.56%	70.56%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%
Public	29.44%	29.44%	29.44%	26.66%	26.68%	26.67%	26.66%	26.66%	26.66%	26.67%	26.66%	26.66%
No. of Shareholders	2,880	2,877	2,838	2,895	2,879	2,827	2,830	2,961	3,110	3,225	3,360	3,476

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	-4.28	0.08	-0.08	0.06	0.08
Diluted EPS (Rs.)	-4.28	0.08	-0.08	0.06	0.08
Cash EPS (Rs.)	-4.27	0.09	-0.06	0.07	0.08
Book Value[Excl.RevalReserv]/Share (Rs.)	10.13	14.40	14.33	14.35	14.19
Book Value[Incl.RevalReserv]/Share (Rs.)	10.13	14.40	14.33	14.35	14.19
Revenue From Operations / Share (Rs.)	8.10	1.54	0.22	0.73	2.45
PBDIT / Share (Rs.)	-4.25	0.15	-0.05	0.09	0.15
PBIT / Share (Rs.)	-4.27	0.14	-0.06	0.08	0.15
PBT / Share (Rs.)	-4.28	0.14	-0.06	0.07	0.10
Net Profit / Share (Rs.)	-4.28	0.07	-0.07	0.05	0.07
PBDIT Margin (%)	-52.50	10.32	-23.56	12.63	6.51
PBIT Margin (%)	-52.67	9.45	-29.04	10.98	6.18
PBT Margin (%)	-52.84	9.45	-29.11	10.60	4.19
Net Profit Margin (%)	-52.82	4.97	-34.94	7.89	3.20
Return on Networth / Equity (%)	-42.27	0.53	-0.55	0.40	0.55
Return on Capital Employeed (%)	-42.00	1.01	-0.45	0.56	1.06
Return On Assets (%)	-42.08	0.52	-0.55	0.39	0.54
Asset Turnover Ratio (%)	0.65	0.10	0.01	0.05	0.16
Current Ratio (X)	795.38	205.92	781.01	43.67	35.10
Quick Ratio (X)	795.38	205.92	781.01	43.67	33.18
Interest Coverage Ratio (X)	-304.63	2389.00	-320.60	33.04	3.27
Interest Coverage Ratio (Post Tax) (X)	-305.48	1152.50	-474.40	21.64	2.61
Enterprise Value (Cr.)	62.69	48.33	44.11	39.38	33.40
EV / Net Operating Revenue (X)	2.58	10.44	64.84	17.81	4.54
EV / EBITDA (X)	-4.91	101.15	-275.19	140.94	69.71
MarketCap / Net Operating Revenue (X)	2.58	10.48	65.27	20.11	6.57
Price / BV (X)	2.06	1.12	1.03	1.03	1.13
Price / Net Operating Revenue (X)	2.58	10.49	65.49	20.11	6.57
EarningsYield	-0.20	0.00	-0.01	0.00	0.00

After reviewing the key financial ratios for Fervent Synergies Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is -4.28. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 23) to -4.28, marking a decrease of 4.36.
For Diluted EPS (Rs.), as of Mar 24, the value is -4.28. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 23) to -4.28, marking a decrease of 4.36.
For Cash EPS (Rs.), as of Mar 24, the value is -4.27. This value is below the healthy minimum of 3. It has decreased from 0.09 (Mar 23) to -4.27, marking a decrease of 4.36.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 10.13. It has decreased from 14.40 (Mar 23) to 10.13, marking a decrease of 4.27.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 10.13. It has decreased from 14.40 (Mar 23) to 10.13, marking a decrease of 4.27.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 8.10. It has increased from 1.54 (Mar 23) to 8.10, marking an increase of 6.56.
For PBDIT / Share (Rs.), as of Mar 24, the value is -4.25. This value is below the healthy minimum of 2. It has decreased from 0.15 (Mar 23) to -4.25, marking a decrease of 4.40.
For PBIT / Share (Rs.), as of Mar 24, the value is -4.27. This value is below the healthy minimum of 0. It has decreased from 0.14 (Mar 23) to -4.27, marking a decrease of 4.41.
For PBT / Share (Rs.), as of Mar 24, the value is -4.28. This value is below the healthy minimum of 0. It has decreased from 0.14 (Mar 23) to -4.28, marking a decrease of 4.42.
For Net Profit / Share (Rs.), as of Mar 24, the value is -4.28. This value is below the healthy minimum of 2. It has decreased from 0.07 (Mar 23) to -4.28, marking a decrease of 4.35.
For PBDIT Margin (%), as of Mar 24, the value is -52.50. This value is below the healthy minimum of 10. It has decreased from 10.32 (Mar 23) to -52.50, marking a decrease of 62.82.
For PBIT Margin (%), as of Mar 24, the value is -52.67. This value is below the healthy minimum of 10. It has decreased from 9.45 (Mar 23) to -52.67, marking a decrease of 62.12.
For PBT Margin (%), as of Mar 24, the value is -52.84. This value is below the healthy minimum of 10. It has decreased from 9.45 (Mar 23) to -52.84, marking a decrease of 62.29.
For Net Profit Margin (%), as of Mar 24, the value is -52.82. This value is below the healthy minimum of 5. It has decreased from 4.97 (Mar 23) to -52.82, marking a decrease of 57.79.
For Return on Networth / Equity (%), as of Mar 24, the value is -42.27. This value is below the healthy minimum of 15. It has decreased from 0.53 (Mar 23) to -42.27, marking a decrease of 42.80.
For Return on Capital Employeed (%), as of Mar 24, the value is -42.00. This value is below the healthy minimum of 10. It has decreased from 1.01 (Mar 23) to -42.00, marking a decrease of 43.01.
For Return On Assets (%), as of Mar 24, the value is -42.08. This value is below the healthy minimum of 5. It has decreased from 0.52 (Mar 23) to -42.08, marking a decrease of 42.60.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.65. It has increased from 0.10 (Mar 23) to 0.65, marking an increase of 0.55.
For Current Ratio (X), as of Mar 24, the value is 795.38. This value exceeds the healthy maximum of 3. It has increased from 205.92 (Mar 23) to 795.38, marking an increase of 589.46.
For Quick Ratio (X), as of Mar 24, the value is 795.38. This value exceeds the healthy maximum of 2. It has increased from 205.92 (Mar 23) to 795.38, marking an increase of 589.46.
For Interest Coverage Ratio (X), as of Mar 24, the value is -304.63. This value is below the healthy minimum of 3. It has decreased from 2,389.00 (Mar 23) to -304.63, marking a decrease of 2,693.63.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -305.48. This value is below the healthy minimum of 3. It has decreased from 1,152.50 (Mar 23) to -305.48, marking a decrease of 1,457.98.
For Enterprise Value (Cr.), as of Mar 24, the value is 62.69. It has increased from 48.33 (Mar 23) to 62.69, marking an increase of 14.36.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.58. This value is within the healthy range. It has decreased from 10.44 (Mar 23) to 2.58, marking a decrease of 7.86.
For EV / EBITDA (X), as of Mar 24, the value is -4.91. This value is below the healthy minimum of 5. It has decreased from 101.15 (Mar 23) to -4.91, marking a decrease of 106.06.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.58. This value is within the healthy range. It has decreased from 10.48 (Mar 23) to 2.58, marking a decrease of 7.90.
For Price / BV (X), as of Mar 24, the value is 2.06. This value is within the healthy range. It has increased from 1.12 (Mar 23) to 2.06, marking an increase of 0.94.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.58. This value is within the healthy range. It has decreased from 10.49 (Mar 23) to 2.58, marking a decrease of 7.91.
For EarningsYield, as of Mar 24, the value is -0.20. This value is below the healthy minimum of 5. It has decreased from 0.00 (Mar 23) to -0.20, marking a decrease of 0.20.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Fervent Synergies Ltd as of June 1, 2025 is: 20.43

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 1, 2025, Fervent Synergies Ltd is Undervalued by 0.15% compared to the current share price 20.40

Intrinsic Value of Fervent Synergies Ltd as of June 1, 2025 is: 14.83

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 1, 2025, Fervent Synergies Ltd is Overvalued by 27.30% compared to the current share price 20.40

Last 5 Year EPS CAGR: -27.41%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (8.62 cr) compared to borrowings (0.00 cr), indicating strong financial stability.	The stock has a low average ROCE of 1.17%, which may not be favorable. The stock has a high average Working Capital Days of 113.08, which may not be favorable. The stock has a high average Cash Conversion Cycle of 59.58, which may not be favorable. The company has not shown consistent growth in sales (12.00) and profit (-0.69).

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fervent Synergies Ltd:
1. Net Profit Margin: -52.82%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: -42% (Industry Average ROCE: 16.7%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: -42.27% (Industry Average ROE: 15.22%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): -305.48
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 795.38
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 30.2 (Industry average Stock P/E: 88.53)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Fervent Synergies Ltd. is a Public Limited Listed company incorporated on 06/07/2009 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH2009PLC193843 and registration number is 193843. Currently Company is involved in the business activities of Wholesale of other basic/manufactured food stuffs. Company's Total Operating Revenue is Rs. 32.46 Cr. and Equity Capital is Rs. 43.75 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	B/7-8, Satyam Shopping Centre, M.G. Road, Ghatkopar (East), Mumbai Maharashtra 400077	info@ferventsynergies.com http://www.ferventsynergies.com

Management
Name	Position Held
Mr. Vijay P Thakkar	Chairman
Mr. Sanjay P Thakkar	Managing Director
Mr. Karan Thakkar	Director & CFO
Mr. Nitin Parikh	Independent Director
Mr. Rajesh Maheshwari	Independent Director
Mrs. Falguni Mehta	Independent Director

FAQ

What is the intrinsic value of Fervent Synergies Ltd?

Fervent Synergies Ltd's intrinsic value (as of 01 June 2025) is ₹20.43 — 0.15% higher the current market price of 20.40, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 89.1 Cr. market cap, FY2025-2026 high/low of ₹32.0/14.6, reserves of 5 Cr, and liabilities of 36 Cr.

What is the Market Cap of Fervent Synergies Ltd?

The Market Cap of Fervent Synergies Ltd is 89.1 Cr..

What is the current Stock Price of Fervent Synergies Ltd as on 01 June 2025?

The current stock price of Fervent Synergies Ltd as on 01 June 2025 is 20.4.

What is the High / Low of Fervent Synergies Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Fervent Synergies Ltd stocks is ₹32.0/14.6.

What is the Stock P/E of Fervent Synergies Ltd?

The Stock P/E of Fervent Synergies Ltd is 30.2.

What is the Book Value of Fervent Synergies Ltd?

The Book Value of Fervent Synergies Ltd is 11.1.

What is the Dividend Yield of Fervent Synergies Ltd?

The Dividend Yield of Fervent Synergies Ltd is 0.00 %.

What is the ROCE of Fervent Synergies Ltd?

The ROCE of Fervent Synergies Ltd is 7.47 %.

What is the ROE of Fervent Synergies Ltd?

The ROE of Fervent Synergies Ltd is 7.47 %.

What is the Face Value of Fervent Synergies Ltd?

The Face Value of Fervent Synergies Ltd is 10.0.